Management of Cryptogenic Stroke secondary to large ASD with percutaneous Occluder Device and Antiplatelet drugs.

Authors

Riya Gupta, Loyola Medicine MacNeal HospitalFollow
Naveed Iqbal, Loyola Medicine MacNeal HospitalFollow

Author Credentials

First author: Riya Gupta, MD Internal Medicine PGY-3 Loyola Medicine MacNeal Hospital, Berwyn, Illinois

Author ORCID Identifier

0000-0001-8021-8170

Keywords

Atrial septal defect, Cryptogenic stroke, Atrial septal aneurysm, Intracardiac echocardiography

Disciplines

Cardiology | Medicine and Health Sciences

Abstract

Atrial septal defects (ASD) represent the most common congenital heart disease diagnosed in adult population and can present with variable clinical findings. Recent literature emphasizes the importance of management of ASD especially if it is associated with structural right heart changes such as RV dysfunction, right ventricular enlargement, arrythmias or paradoxical embolism.

The decision between medical therapy versus surgical closure of ASD is a common clinical conundrum especially in the setting of cryptogenic stroke.

Recommended Citation

Gupta R, Iqbal N. Management of Cryptogenic Stroke secondary to large ASD with percutaneous Occluder Device and Antiplatelet drugs.. Marshall J Med. 2024; 10(1) DOI: https://doi.org/10.33470/2379-9536.1415.